FOLIC ACID ANTAGONIST. EFFECTS ON THE CELL AND THE PATIENT. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.
D001669:Biochemical Phenomena; D001671:Biochemistry; D001853:Bone Marrow; D002648:Child; D002822:Choriocarcinoma; D004848:Epithelium; D005260:Female; D005492:Folic Acid; D005493:Folic Acid Antagonists; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008660:Metabolism; D009316:National Institutes of Health (U.S.); D010336:Pathology; D010600:Pharmacology; D011247:Pregnancy; D014116:Toxicology; D014328:Trophoblastic Neoplasms; D014481:United States
D005493:Folic Acid Antagonists; D005492:Folic Acid
BIOCHEMISTRY; BONE MARROW; CHILD; CHORIOCARCINOMA; EPITHELIUM; FOLIC ACID ANTAGONISTS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; METABOLISM; PATHOLOGY; PHARMACOLOGY; TOXICOLOGIC REPORT; TROPHOBLASTIC TUMOR